Viking Therapeutics (VKTX) Retained Earnings (2014 - 2026)
Viking Therapeutics' (VKTX) quarterly Retained Earnings came in at -$1.1 billion in Q2 2026, down 89.27% year-over-year from -$10.6 billion in Q2 2025, and down 12.73% quarter-over-quarter from -$1.0 billion in Q1 2026.
Powered by 
Analysis
Viking Therapeutics (VKTX) Retained Earnings (2014 - 2026) Analysis & Trends
Viking Therapeutics has disclosed Retained Earnings across 13 years of filings, most recently posting -$1.1 billion for Q2 2026.
- In Q2 2026, Retained Earnings fell 89.27% year-over-year to -$1.1 billion; the TTM figure through Jun 2026 stood at -$1.1 billion (down 89.27% YoY), while the FY2025 annual figure was -$847.5 million, down 73.71% from the prior year.
- Retained Earnings came in at -$1.1 billion for Q2 2026 at Viking Therapeutics, down from -$1.0 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$239.3 million in Q1 2022 to a low of -$1.1 billion in Q2 2026.
- Average Retained Earnings over 5 years is -$501.0 million, with a median of -$416.4 million recorded in 2024.
- Year-over-year, Retained Earnings retreated 28.06% in 2024 and tumbled 89.27% in 2026.
- Over 5 years, Retained Earnings stood at -$292.0 million in 2022, then slipped by 29.41% to -$377.9 million in 2023, then declined by 29.1% to -$487.9 million in 2024, then plunged by 73.71% to -$847.5 million in 2025, then plunged by 33.79% to -$1.1 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$1.1 billion in Q2 2026, -$1.0 billion in Q1 2026, and -$847.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 9.53 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Viking Therapeutics | 4.86 Bn | 4.86 Bn | - | -1.13 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.13 Bn |
| Mar 31, 2026 | -1.01 Bn |
| Dec 31, 2025 | -847.55 Mn |
| Sep 30, 2025 | -689.88 Mn |
| Jun 30, 2025 | -599.10 Mn |
| Mar 31, 2025 | -533.54 Mn |
| Dec 31, 2024 | -487.91 Mn |
| Sep 30, 2024 | -452.49 Mn |
| Jun 30, 2024 | -427.55 Mn |
| Mar 31, 2024 | -405.30 Mn |
| Dec 31, 2023 | -377.94 Mn |
| Sep 30, 2023 | -353.34 Mn |
| Jun 30, 2023 | -330.81 Mn |
| Mar 31, 2023 | -311.58 Mn |
| Dec 31, 2022 | -292.05 Mn |
| Sep 30, 2022 | -272.49 Mn |
| Jun 30, 2022 | -256.72 Mn |
| Mar 31, 2022 | -239.29 Mn |
| Dec 31, 2021 | -223.18 Mn |
| Sep 30, 2021 | -210.83 Mn |
API Access
Viking Therapeutics Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();